Cancer turns out to be a p53 protein aggregation disease

	Tweet

Protein aggregation, generally associated with Alzheimer’s and mad cow disease, turns out to play a significant role in cancer. In a paper published in Nature Chemical Biology, Frederic Rousseau and Joost Schymkowitz of VIB, K.U.Leuven and Vrije Universiteit Brussel describe that certain mutations of p53, an important tumor suppressor, cause the protein to misfold in a way that the proteins start to aggregate. This not only disrupts the protective function of normal p53, but of other related proteins as well.

p53 plays a central role in protection against cancer
In the study, the focus was on the p53 protein which plays a key role in protecting the body against cancer. If p53 works normally, it controls cell division. If p53 control ceases - e.g. when there is a mutation in the protein - the cells start to divide in an uncontrolled manner and this may result in a tumor. Mutations in p53 are observed in about half of cancer cases, making the protein an important target in the development of new cancer therapies.

Mutated p53 aggregates
“We have revealed a new mechanism for the action of mutant p53,” Joost Schymkowitz and Frederic Rousseau of VIB, Vrije Universiteit Brussel and K.U. Leuven say. “Mutations in p53 cause the protein to lose its protective function. The proteins change in shape, hook into each other and begin to aggregate. The active p53 disappears from the cell and can no longer carry out its control function properly.” The mechanism has been encountered in about one third of p53 mutations. 

Complete switch of character
Moreover, the mutations cause p53 to assume a completely different character.  From being a protective factor, the mutated p53 changes into a substance which in fact speeds up tumor growth. It seems to form aggregates with control substances (p63 and p73) in the cell, causing them to lose their function as well.

Other proteins underlying cancer and Alzheimer
Even though the underlying principle – protein aggregation - occurs similarly in particular cancers, Alzheimer and systemic amyloidosis, the diseases are otherwise totally unconnected with each other. In cancer, the clustering of p53 protein leads to uncontrolled cell growth. In Alzheimer, clustering of the beta-amyloid protein causes brain cells to die off.

Questions
As this research can give rise to patient related questions, anyone interested address them to

Financing
This research was financed by FWO, Chinese Science Council and VIB.

Scientific publication
Jie Xu et al, Gain of function of mutant p53 by coaggregation with multiple tumor suppressors, Nature Chemical Biology

Research team
This research was conducted by Jie Xu under the supervision of Frederic Rousseau en Joost Schymkowitz of VIB, Vrije Universiteit Brussel en K.U.Leuven. Also Jean-Christophe Marine and Diether Lambrechts, other VIB scientists attached to K.U.Leuven collaborated to the work.

RELATED STORIES:
Nerve chemical may signal aggressive cancer   Custom-made cancer cell attacks   Roche says can start to talk about curing cancer   Cancer Drug Aids an Anti-Cancer Virus   Personalized diets may offer relief to advanced cancer patients   New Hybrid virus may aid treatment of cancer   World Cancer Day Points to Prevention   Targeted Virus Compels Cancer Cells to Eat Themselves   Pfizer’s Sutent improves survival in cancer study   Cancer rates on the rise in young people   Study shows promise for new cancer-stopping therapy   Aiding cancer therapy by mathematically modeling tumor-immune interactions   New Therapeutic Target for Melanoma Identified   Children could be saved from neuroblastoma using antibody therapy   Cancer deaths fall, new diagnoses stable   Promise for Treatment of Renal Cell Cancer   Snoring ‘can raise cancer risk five-fold’   Targeting cholesterol may help slow glioblastoma   More than Half of Nurses Have Stopped or Delayed Patients’ Chemotherapy Treatment   New DNA technique leads to a breakthrough in child cancer research   Workers in No-Smoking Restaurants Show Lower Carcinogen Levels   Research Team Identifies Novel Anti-Cancer Drug from the Sea

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]